Esteban Ortiz-Prado, Isaac A Suárez-Sangucho, Jorge Vasconez-Gonzalez, Pablo A Santillan-Roldán, Melisa Villavicencio-Gomezjurado, Camila Salazar-Santoliva, Andrea Tello-De-la-Torre, Juan S Izquierdo-Condoy
{"title":"大流行悖论:COVID-19危机如何将疫苗犹豫转变为一把双刃剑","authors":"Esteban Ortiz-Prado, Isaac A Suárez-Sangucho, Jorge Vasconez-Gonzalez, Pablo A Santillan-Roldán, Melisa Villavicencio-Gomezjurado, Camila Salazar-Santoliva, Andrea Tello-De-la-Torre, Juan S Izquierdo-Condoy","doi":"10.1080/21645515.2025.2543167","DOIUrl":null,"url":null,"abstract":"<p><p>The rapid development of COVID-19 vaccines was a landmark achievement that saved millions of lives. However, this success also intensified vaccine hesitancy, as misinformation, evolving public health guidelines, and growing distrust in institutions fueled anti-vaccine sentiment. In this opinion piece, we explore the paradoxical legacy of the COVID-19 vaccination campaign - how a global scientific triumph simultaneously gave rise to an emboldened anti-vaccine movement. Drawing on international data, we highlight the association between baseline vaccine acceptance and subsequent booster uptake and interpret these trends through the lens of the Health Belief Model. We further examine the psychological, cultural, political, and structural drivers of hesitancy and outline key strategies to rebuild public trust. Addressing this crisis requires proactive, evidence-informed, and culturally sensitive approaches to safeguard the future of global immunization efforts.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"21 1","pages":"2543167"},"PeriodicalIF":3.5000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344792/pdf/","citationCount":"0","resultStr":"{\"title\":\"Pandemic paradox: How the COVID-19 crisis transformed vaccine hesitancy into a two-edged sword.\",\"authors\":\"Esteban Ortiz-Prado, Isaac A Suárez-Sangucho, Jorge Vasconez-Gonzalez, Pablo A Santillan-Roldán, Melisa Villavicencio-Gomezjurado, Camila Salazar-Santoliva, Andrea Tello-De-la-Torre, Juan S Izquierdo-Condoy\",\"doi\":\"10.1080/21645515.2025.2543167\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The rapid development of COVID-19 vaccines was a landmark achievement that saved millions of lives. However, this success also intensified vaccine hesitancy, as misinformation, evolving public health guidelines, and growing distrust in institutions fueled anti-vaccine sentiment. In this opinion piece, we explore the paradoxical legacy of the COVID-19 vaccination campaign - how a global scientific triumph simultaneously gave rise to an emboldened anti-vaccine movement. Drawing on international data, we highlight the association between baseline vaccine acceptance and subsequent booster uptake and interpret these trends through the lens of the Health Belief Model. We further examine the psychological, cultural, political, and structural drivers of hesitancy and outline key strategies to rebuild public trust. Addressing this crisis requires proactive, evidence-informed, and culturally sensitive approaches to safeguard the future of global immunization efforts.</p>\",\"PeriodicalId\":49067,\"journal\":{\"name\":\"Human Vaccines & Immunotherapeutics\",\"volume\":\"21 1\",\"pages\":\"2543167\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344792/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Human Vaccines & Immunotherapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/21645515.2025.2543167\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2025.2543167","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Pandemic paradox: How the COVID-19 crisis transformed vaccine hesitancy into a two-edged sword.
The rapid development of COVID-19 vaccines was a landmark achievement that saved millions of lives. However, this success also intensified vaccine hesitancy, as misinformation, evolving public health guidelines, and growing distrust in institutions fueled anti-vaccine sentiment. In this opinion piece, we explore the paradoxical legacy of the COVID-19 vaccination campaign - how a global scientific triumph simultaneously gave rise to an emboldened anti-vaccine movement. Drawing on international data, we highlight the association between baseline vaccine acceptance and subsequent booster uptake and interpret these trends through the lens of the Health Belief Model. We further examine the psychological, cultural, political, and structural drivers of hesitancy and outline key strategies to rebuild public trust. Addressing this crisis requires proactive, evidence-informed, and culturally sensitive approaches to safeguard the future of global immunization efforts.
期刊介绍:
(formerly Human Vaccines; issn 1554-8619)
Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.
Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.